Using automated clinical data for risk adjustment - Development and validation of six disease-specific mortality predictive models for pay-for-performance

被引:82
|
作者
Tabak, Ying P.
Johannes, Richard S.
Silber, Jeffrey H.
机构
[1] Cardinal Hlth MediQual Business, Dept Clin Res, Marlborough, MA 01752 USA
[2] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Gastroenterol, Boston, MA 02115 USA
[3] Childrens Hosp Philadelphia, Ctr Outcomes Res, Philadelphia, PA 19104 USA
[4] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA
[5] Univ Penn, Wharton Sch, Philadelphia, PA 19104 USA
关键词
automated clinical data; laboratory data; relative contribution; risk adjustment; pay-for-performance; public accountability; predicting mortality; stroke; pneumonia; acute myocardial infarction; congestive heart failure; septicemia;
D O I
10.1097/MLR.0b013e31803d3b41
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Clinically plausible risk-adjustment methods are needed to implement pay-for-performance protocols. Because billing data lacks clinical precision, may be gamed, and chart abstraction is costly, we sought to develop predictive models for mortality that maximally used automated laboratory data and intentionally minimized the use of administrative data (Laboratory Models). We also evaluated the additional value of vital signs and altered mental status (Full Models). Methods: Six models predicting in-hospital mortality for ischemic and hemorrhagic stroke, pneumonia, myocardial infarction, heart failure, and septicemia were derived from 194,903 admissions in 2000-2003 across 71 hospitals that imported laboratory data. Demographics, admission-based labs, International Classification of Diseases (ICD)-9 variables. vital signs, and altered mental status were sequentially entered as covariates. Models were validated using abstractions (629,490 admissions) from 195 hospitals. Finally, we constructed hierarchical models to compare hospital performance using the Laboratory Models and the Full Models. Results: Model c-statistics ranged from 0.81 to 0.89. As constructed. laboratory findings contributed more to the prediction of death compared with any other risk factor characteristic groups across most models except for stroke, where altered mental status was more important. Laboratory variables were between 2 and 67 times more important in predicting mortality than ICD-9 variables. The hospital-level risk-standardized mortality rates derived from the Laboratory Models were highly correlated with the results derived from the Full Models (average rho = 0.92). Conclusions: Mortality can be well predicted using models that maximize reliance on objective pathophysiologic variables whereas minimizing input from billing data. Such models should be less susceptible to the vagaries of billing information and inexpensive to implement.
引用
收藏
页码:789 / 805
页数:17
相关论文
共 19 条
  • [1] Development and Validation of a Disease-Specific Risk Adjustment System Using Automated Clinical Data
    Tabak, Ying P.
    Sun, Xiaowu
    Derby, Karen G.
    Kurtz, Stephen G.
    Johannes, Richard S.
    HEALTH SERVICES RESEARCH, 2010, 45 (06) : 1815 - 1835
  • [2] Development and independent validation of prospective mortality risk-adjustment models for Alzheimer's disease and related dementias based on automated pharmacy and medical claims data
    Ricci, JF
    Silverstein, MD
    Martin, BC
    ANNALS OF NEUROLOGY, 2001, 50 (03) : S75 - S75
  • [3] Development and validation of pretreatment nomogram for disease-specific mortality in gastric cancer-A competing risk analysis
    Bando, Etsuro
    Ji, Xinge
    Kattan, Michael W.
    Bencivenga, Maria
    de Manzoni, Giovanni
    Terashima, Masanori
    CANCER MEDICINE, 2021, 10 (21): : 7561 - 7571
  • [4] AN AUTOMATED MODEL TO IDENTIFY HEART FAILURE PATIENTS AT RISK FOR READMISSION OR DEATH USING ELECTRONIC MEDICAL RECORD DATA: IMPLICATIONS FOR PAY-FOR-PERFORMANCE
    Amarasingham, Ruben
    Tabak, Ying
    Swanson, Timothy
    Ma, Ying
    Moore, Billy
    Clark, Christopher
    Halm, Ethan
    Drazner, Mark
    Zhang, Song
    Reed, Gary
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2010, 25 : 222 - 222
  • [5] Using classification models for the generation of disease-specific medications from biomedical literature and clinical data repository
    Wang, Liqin
    Haug, Peter J.
    Del Fiol, Guilherme
    JOURNAL OF BIOMEDICAL INFORMATICS, 2017, 69 : 259 - 266
  • [6] Development and independent validation of prospective mortality risk-adjustment models for incident cases of ischemic and hemorrhagic stroke based on automated pharmacy and medical claims data
    Ricci, JF
    Fagan, SC
    Martin, BC
    ANNALS OF NEUROLOGY, 2001, 50 (03) : S70 - S70
  • [7] Automated Identification of Common Disease-Specific Outcomes for Comparative Effectiveness Research Using ClinicalTrials.gov: Algorithm Development and Validation Study
    Elghafari, Anas
    Finkelstein, Joseph
    JMIR MEDICAL INFORMATICS, 2021, 9 (02)
  • [8] Development and Validation of a Clinical Prognostic Stage Group System for Nonmetastatic Prostate Cancer Using Disease-Specific Mortality Results From the International Staging Collaboration for Cancer of the Prostate
    Dess, Robert T.
    Suresh, Krithika
    Zelefsky, Michael J.
    Freedland, Stephen J.
    Mahal, Brandon A.
    Cooperberg, Matthew R.
    Davis, Brian J.
    Horwitz, Eric M.
    Terris, Martha K.
    Amling, Christopher L.
    Aronson, William J.
    Kane, Christopher J.
    Jackson, William C.
    Hearn, Jason W. D.
    Deville, Curtiland
    DeWeese, Theodore L.
    Greco, Stephen
    McNutt, Todd R.
    Song, Daniel Y.
    Sun, Yilun
    Mehra, Rohit
    Kaffenberger, Samuel D.
    Morgan, Todd M.
    Nguyen, Paul L.
    Feng, Felix Y.
    Sharma, Vidit
    Tran, Phuoc T.
    Stish, Bradley J.
    Pisansky, Thomas M.
    Zaorsky, Nicholas G.
    Moraes, Fabio Ynoe
    Berlin, Alejandro
    Finelli, Antonio
    Fossati, Nicola
    Gandaglia, Giorgio
    Briganti, Alberto
    Carroll, Peter R.
    Karnes, R. Jeffrey
    Kattan, Michael W.
    Schipper, Matthew J.
    Spratt, Daniel E.
    JAMA ONCOLOGY, 2020, 6 (12) : 1912 - 1920
  • [9] Using Enriched Observational Data to Develop and Validate Age-specific Mortality Risk Adjustment Models for Hospitalized Pediatric Patients
    Tabak, Ying P.
    Sun, Xiaowu
    Hyde, Linda
    Yaitanes, Ayla
    Derby, Karen
    Johannes, Richard S.
    MEDICAL CARE, 2013, 51 (05) : 437 - 445
  • [10] Re: Development and Validation of a Clinical Prognostic Stage Group System for Nonmetastatic Prostate Cancer Using Disease-specific Mortality Results from the International Staging Collaboration for Cancer of the Prostate
    Ozen, Haluk
    Turkeri, Levent
    EUROPEAN UROLOGY, 2022, 81 (03) : 315 - 315